window.dataLayer = window.dataLayer || []; (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-5L46PPF2');

EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

FT 19 - Flash talks on Hereditary Angioedema

Sunday 02 Jun, 15:00 PM - 16:30 PM Valencia, Spain
Palma Flash Talks
15:00
Burden of Disease and Health-Related Quality of Life Impairment in Adult Patients With Hereditary Angioedema: Results From a Multinational Survey
15:07
Analysis of prodromal symptoms and need for short-term prophylaxis in hereditary angioedema patients under long-term prophylaxis
15:14
Genital Attacks in Hereditary Angioedema And Their Effects On Sexual Life
15:21
Understanding treatment switching patterns and continuation rates for patients with hereditary angioedema receiving lanadelumab: analysis of real-world data
15:28
Prospective monitoring of clinical outcomes and laboratory markers of hereditary angioedema in patients on long-term prophylaxis with lanadelumab: One-year follow-up
15:35
Under-representation and -reporting of race in global hereditary angioedema trials: A hidden yet alarming source of disparities
15:42
Long-term Real-Life Effectiveness and Tolerability of Lanadelumab in Hereditary Angioedema: The Bulgarian Experience
15:49
Comorbidities in hereditary angioedema patients in Canada: a quantitative survey study
15:56
Hereditary Angioedema (HAE) Patients Answer: Why Do Attacks Go Untreated?
16:03
Turkish National Hereditary Angioedema and Acquired Angioedema Registry, Established to Encourage Standardizing the Care and Management of the Disease. HAE/AAE-TR National Hereditary and Acquired Angioedema Registry Group

Chairs

Speakers